Pharmafile Logo
Pharmafocus logo
Advanced Search

h1n1

Showing 15 posts of 34 posts found.

Europe approves two swine-flu vaccines

September 30, 2009
Sales and Marketing EU, GSK, Novartis, h1n1

The European Commission has approved the use of two vaccines for the pandemic H1N1 virus, commonly known as swine flu. …

News

Sanofi on track to deliver flu vaccine

September 30, 2009
Sales and Marketing Sanofi, h1n1

French company Sanofi-Pasteur is on track to deliver its H1N1 flu vaccine over the next two months, chief executive Chris …

News

WHO welcomes pandemic vaccine donations to developing world

September 21, 2009
Sales and Marketing h1n1, hc, vaccines

The World Health Organisation has applauded donations of H1N1 vaccine made by the US, Australia, Brazil, France, Italy, New Zealand, …

News

GSK encouraged by first H1N1 vaccines results

September 15, 2009
Sales and Marketing GSK, h1n1

Results from the first trial of GlaxoSmithKline's new pandemic swine flu vaccine have been revealed. A German study of 130 …

News

Novartis swine-flu jab effective in single dose

September 3, 2009
Manufacturing and Production, Research and Development, Sales and Marketing Novartis, h1n1

A study of Novartis' pandemic swine-flu jab shows it is potentially protective after just one dose, which could help eke …

News

Pandemic planning: GSK’s Dr Neil Formica

September 1, 2009
Research and Development GlaxoSmithKline, Vaccine, h1n1

 

Feature

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009
Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …

News

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009
Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …

News

Vulnerable groups first in line for UK swine flu jabs

August 14, 2009
Research and Development, Sales and Marketing NHS, h1n1

The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …

News

Sanofi submits FDA application for swine flu vaccine

August 10, 2009
Research and Development, Sales and Marketing Sanofi-Aventis, h1n1

Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …

News

Poor antigen yields limiting H1N1 vaccine supplies, says WHO

July 15, 2009
Manufacturing and Production, Research and Development h1n1, vaccines

Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …

News

Sanofi to donate millions of flu vaccines for developing world

June 18, 2009
Research and Development Sanofi-Aventis, h1n1, vaccines

Sanofi-Aventis is to set aside 100 million flu vaccine doses for the developing world in order to fight the emerging …

News

Pandemic declaration will not change UK’s response

June 12, 2009
NHS, h1n1

The Department of Health has insisted there will be no "material change" to the UK's preparations for swine flu. The …

News

Companies poised for swine flu vaccine drive

May 29, 2009
Research and Development, Sales and Marketing US, h1n1, vaccines

Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …

News

UK a step closer to new swine flu vaccine

May 11, 2009
Research and Development NHS, h1n1

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025